Skip to main content
. 2018 Aug 9;30(12):541–550. doi: 10.1093/intimm/dxy051

Fig. 2.

Fig. 2.

Genetically engineered T cells for immunotherapy. T-cell immunotherapy involves isolating a patient’s own cells and engineering them to recognize a tumor-specific protein, enabling them to seek out and destroy the cancer upon re-infusion. CAR T cells represent an important T-cell immunotherapy approach.